212 related articles for article (PubMed ID: 24548457)
21. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
[TBL] [Abstract][Full Text] [Related]
22. Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models.
Kryukova EV; Ivanov IA; Lebedev DS; Spirova EN; Egorova NS; Zouridakis M; Kasheverov IE; Tzartos SJ; Tsetlin VI
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469507
[TBL] [Abstract][Full Text] [Related]
23. RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia.
Christensen SB; Hone AJ; Roux I; Kniazeff J; Pin JP; Upert G; Servent D; Glowatzki E; McIntosh JM
Front Cell Neurosci; 2017; 11():219. PubMed ID: 28785206
[TBL] [Abstract][Full Text] [Related]
24. Stoichiometry of the alpha9alpha10 nicotinic cholinergic receptor.
Plazas PV; Katz E; Gomez-Casati ME; Bouzat C; Elgoyhen AB
J Neurosci; 2005 Nov; 25(47):10905-12. PubMed ID: 16306403
[TBL] [Abstract][Full Text] [Related]
25. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
[TBL] [Abstract][Full Text] [Related]
26. Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels.
Daly NL; Callaghan B; Clark RJ; Nevin ST; Adams DJ; Craik DJ
J Biol Chem; 2011 Mar; 286(12):10233-7. PubMed ID: 21252227
[TBL] [Abstract][Full Text] [Related]
27. Alkaloid ligands enable function of homomeric human α10 nicotinic acetylcholine receptors.
Hone AJ; McIntosh JM
Front Pharmacol; 2022; 13():981760. PubMed ID: 36188578
[TBL] [Abstract][Full Text] [Related]
28. Globular and ribbon isomers of Conus geographus α-conotoxins antagonize human nicotinic acetylcholine receptors.
Tae HS; Gao B; Jin AH; Alewood PF; Adams DJ
Biochem Pharmacol; 2021 Aug; 190():114638. PubMed ID: 34062129
[TBL] [Abstract][Full Text] [Related]
29. Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.
Huynh PN; Harvey PJ; Gajewiak J; Craik DJ; Michael McIntosh J
Biochem Pharmacol; 2020 Nov; 181():114124. PubMed ID: 32593612
[TBL] [Abstract][Full Text] [Related]
30. Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M
Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168
[TBL] [Abstract][Full Text] [Related]
31. From Crystal Structures of RgIA4 in Complex with
Pan S; Fan Y; Zhu X; Xue Y; Luo S; Wang X
Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940708
[TBL] [Abstract][Full Text] [Related]
32. A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain.
Klimis H; Adams DJ; Callaghan B; Nevin S; Alewood PF; Vaughan CW; Mozar CA; Christie MJ
Pain; 2011 Feb; 152(2):259-266. PubMed ID: 20889259
[TBL] [Abstract][Full Text] [Related]
33. The α9α10 acetylcholine receptor: A non-neuronal nicotinic receptor.
Elgoyhen AB
Pharmacol Res; 2023 Apr; 190():106735. PubMed ID: 36931539
[TBL] [Abstract][Full Text] [Related]
34. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor.
Li X; Tae HS; Chu Y; Jiang T; Adams DJ; Yu R
Pharmacol Ther; 2021 Jun; 222():107792. PubMed ID: 33309557
[TBL] [Abstract][Full Text] [Related]
35. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
[TBL] [Abstract][Full Text] [Related]
36. The α9α10 nicotinic acetylcholine receptors antagonist α-conotoxin RgIA reverses colitis signs in murine dextran sodium sulfate model.
AlSharari SD; Toma W; Mahmood HM; Michael McIntosh J; Imad Damaj M
Eur J Pharmacol; 2020 Sep; 883():173320. PubMed ID: 32645334
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological properties of alpha 9 alpha 10 nicotinic acetylcholine receptors revealed by heterologous expression of subunit chimeras.
Baker ER; Zwart R; Sher E; Millar NS
Mol Pharmacol; 2004 Feb; 65(2):453-60. PubMed ID: 14742688
[TBL] [Abstract][Full Text] [Related]
38. Structure-Activity Studies Reveal the Molecular Basis for GABA
Sadeghi M; Carstens BB; Callaghan BP; Daniel JT; Tae HS; O'Donnell T; Castro J; Brierley SM; Adams DJ; Craik DJ; Clark RJ
ACS Chem Biol; 2018 Jun; 13(6):1577-1587. PubMed ID: 29746088
[TBL] [Abstract][Full Text] [Related]
39. DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-
Tae HS; Ortells MO; Tekarli BJ; Manetti D; Romanelli MN; McIntosh JM; Adams DJ; Arias HR
ACS Chem Neurosci; 2023 Jul; 14(14):2537-2547. PubMed ID: 37386821
[TBL] [Abstract][Full Text] [Related]
40. Positive modulation of the α9α10 nicotinic cholinergic receptor by ascorbic acid.
Boffi JC; Wedemeyer C; Lipovsek M; Katz E; Calvo DJ; Elgoyhen AB
Br J Pharmacol; 2013 Feb; 168(4):954-65. PubMed ID: 22994414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
